KCNJ5 and metabolic syndrome: first reported that APA patients with KCNJ5 mutations had fewer MetS, lower triglyceride (TG) levels, waist circumference, and subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) area than those without KCNJ5 mutations even after matching for age (103).